NASDAQ · Drug Manufacturers - Specialty & Generic

IMCC (IMCC) Stock

$0.12 +0.26% NASDAQ: IMCC Healthcare

Valuation

MetricValue
Price$0.12
Market Cap$357295
P/E Ratio-1062.50
P/B Ratio4.72
P/S Ratio0.68
EPS (TTM)$-2.67
52-Week High$3.75
52-Week Low$0.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.03%
ROA-0.33%
ROCE-3.24%
Gross Margin-20.00%
Operating Margin-21.82%
Net Margin-0.53%
Debt/Equity4.44
Current Ratio0.68

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$54.0M$49.0M$54.0M$55.0M
Operating Profit$-23.0M$-31.0M$-13.0M$-10.0M$-12.0M
Net Profit$-18.0M$-189.0M$-9.0M$-11.0M$-11.0M
EPS$-3.00$-161.88$-4.45$-4.51$-2.67
Op Margin-67.6%-56.7%-26.2%-18.9%-21.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$287.0M$61.0M$49.0M$39.0M$32.0M
Total Liabilities$82.0M$37.0M$35.0M$36.0M$35.0M
Cash$14.0M$2.0M$2.0M$1.0M$3.0M
Borrowings$29.0M$12.0M$14.0M$18.0M$16.0M

Latest News

IM Cannabis Closes Convertible Note Financing MT Newswires · Jul 1, 2026 IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing PR Newswire · Jul 1, 2026 IM Cannabis to Sell European-Focused Assets MT Newswires · Jun 18, 2026 IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million PR Newswire · Jun 18, 2026 Top Premarket Gainers MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-13.0M$-8.0M$-1.0M$5.0M
Investing Cash Flow$-14.0M$-3.0M$-2.0M$-1.0M$-1.0M
Financing Cash Flow$13.0M$-2.0M$8.0M$4.0M$-5.0M
Net Cash Flow$5.0M$-11.0M$-1.0M$-1.0M$2.0M
Free Cash Flow$-39.0M$-14.0M$-9.0M$-1.0M$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-4.85
EV / EBITDA47.80
FCF Yield23.21%
Quick Ratio0.62
Interest Coverage-16.00
Return 1Y-95.24%
Return 3Y-97.35%
Return 5Y-99.95%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKAN $5.31 -16.90% -0.06 $171863 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
GRI $1.46 -5.81% -0.33 $131155 0.00%
JAGXJaguar Health, Inc. $0.93 -3.48% 0.00 $61962 0.00%
MOVE $10.76 -0.55% -2.31 $8.16M 0.00%

About IMCC

IMCC stock trades at $0.12 with a market capitalization of $357295. The stock is valued at a price-to-earnings (P/E) ratio of -1062.50, price-to-book of 4.72, price-to-sales of 0.68. Over the past 52 weeks the stock has ranged between $0.10 and $3.75, and currently trades 96.8% below its 52-week high.

On profitability, IMCC generates a return on equity (ROE) of -3.03%, return on capital employed of -3.24%, an operating margin of -21.82%, a net profit margin of -0.53%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides